{
    "Trade/Device Name(s)": [
        "iHealth BG1 Align Mini Gluco-Monitoring System",
        "iHealth Align Mini Gluco-Monitoring System"
    ],
    "Submitter Information": "Andon Health Co., Ltd.",
    "510(k) Number": "K133790",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120813"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP"
    ],
    "Summary Letter Date": "May 22, 2014",
    "Summary Letter Received Date": "April 25, 2014",
    "Submission Date": "December 3, 2013",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Calculator/data processing module, for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iHealth BG1 meter",
        "iOS device"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry",
        "Glucose oxidase"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "In vitro diagnostic"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancet",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for iHealth BG1 Align Mini Gluco-Monitoring System using electrochemical biosensor for quantitative measurement of glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various sites for single-person, self-testing at home to monitor effectiveness of diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}